Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A12 | Q96S37 | 5/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | FNTA | P49354 | 1/20 | 0.38 |
| ▸ | FNTB | P49356 | 1/20 | 0.38 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.38 |
| ▸ | SCN9A | Q15858 | 8/20 | 0.37 |
| ▸ | AR | P10275 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 1/20 | 0.36 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.36 |
| ▸ | ERBB3 | P21860 | 1/20 | 0.36 |
| ▸ | ERBB4 | Q15303 | 1/20 | 0.36 |
| ▸ | CNR1 | P21554 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4151888 | 0.88 | SLC22A12 (0.44) | SLC22A12SCN9A | |
| SCHEMBL4145790 | 0.88 | PIK3CA (0.37) | SCN9AALDH1A1HPGDNPSR1 | |
| SCHEMBL4151856 | 0.88 | KDM4E (0.39) | SMN1; SMN2SCN9AARALDH1A1HPGD | |
| Potassium SCHEMBL4159398 | 0.87 | KDM4E (0.38) | SMN1; SMN2SCN9AARALDH1A1HPGD | |
| SCHEMBL4159392 | 0.87 | KDM4E (0.38) | SMN1; SMN2SCN9AARALDH1A1HPGD | |
| SCHEMBL2532037 | 0.87 | ALDH1A1 (0.41) | LMNASMN1; SMN2SCN9AALDH1A1HPGD | |
| SCHEMBL4159263 | 0.85 | SLC22A12 (0.41) | SLC22A12FNTAFNTBPGGT1BSCN9A | |
| SCHEMBL4146247 | 0.85 | XDH (0.42) | SMN1; SMN2SCN9A | |
| SCHEMBL4154840 | 0.84 | SLC22A12 (0.44) | SLC22A12SMN1; SMN2FNTAFNTBPGGT1B | |
| SCHEMBL2535698 | 0.83 | SLC22A12 (0.44) | SLC22A12SCN9AALDH1A1HPGDNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3263109-B1 | DRUG FOR PREVENTING AND/OR TREATING DEMENTIA | NAT UNIV CORP TOTTORI UNIV (JP) | 2020-06-17 | — | — | EP | claimed |
| US-20090149452-A1 | XANTHINE OXIDASE INHIBITOR | NIPPON CHEMIPHAR CO., LTD. (JP) | 2009-06-11 | — | — | US | disclosed |
| EP-1911760-A1 | XANTHINE OXIDASE INHIBITOR | Nippon Chemiphar Co., Ltd. (JP) | 2008-04-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090149452-A1 | XANTHINE OXIDASE INHIBITOR | XDH, PNPO, CBR1 | SLC22A12 1556/4885LMNA 2053/4885ADRB2 279/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.